Jasper Therapeutics(JSPR)
$13.68+0.31 (+2.32%)
JSPR
Jasper Therapeutics financials statements
$13.68
At close:+0.31 (+2.32%)
Want to see JSPR full AI Analyst Report?
Jasper Therapeutics (JSPR) Income Statement
1,073 Followers
Jasper Therapeutics Income Statement
Last quarter (Q3 2026), Jasper Therapeutics's total revenue was $8.00M. In Q3, Jasper Therapeutics's net income was $0.00. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.06M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 79.46M | $ 76.24M | $ 68.86M | $ 51.20M | $ 36.83M | |
| Depreciation and Amortization | $ 1.06M | $ 1.37M | $ 1.11M | $ 975.00K | $ 377.00K |
| $ -74.75M | $ -69.90M | $ -63.36M | $ -36.71M | $ -30.26M | |
| $ -80.52M | $ -76.24M | $ -68.86M | $ -51.20M | $ -36.83M | |
| $ 4.72M | $ 4.97M | $ 4.40M | $ 13.51M | $ 6.20M | |
| $ -75.80M | $ -71.27M | $ -64.47M | $ -37.69M | $ -30.64M | |
| $ -75.80M | $ -71.27M | $ -64.47M | $ -37.69M | $ -30.64M | |
| Per Share Metrics | |||||
| Basic EPS | $ -118.50 | $ -146.70 | $ -185.40 | $ -309.90 | $ -806.70 |
| Diluted EPS | $ -118.50 | $ -146.70 | $ -185.40 | $ -309.90 | $ -806.70 |
| Weighted Average Shares Outstanding | 638.94K | 486.13K | 347.97K | 121.60K | 37.97K |
| Weighted Average Shares Outstanding (Diluted) | 638.94K | 486.16K | 347.97K | 121.61K | 37.98K |
Currency in USD

